X
08Jun

FDA Signals a Deliberative Approach to Cannabis at Public Hearing

While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By: Wilson Sonsini Goodrich & Rosati
Source Url: https://www.jdsupra.com/legalnews/fda-signals-a-deliberative-approach-to-46336/

Related

Proposed Regulation Would Provide Compliance Relief to Administrators of Multiple Employer Defined Contribution Plans

Administrators of Multiple Employer Plans (“MEPs”)­–in which employers from different controlled ...

Read More >

Appeals Court Says No FLSA Notice for Employees Who Agree to Arbitrate

On January 24, 2020, the U.S. Court of Appeals for the Seventh Circuit announced a new standard by w...

Read More >

Once in a Lifetime? Rare Battle Won for Golden State Employers—but the PAGA War Rages On

While talking heads focused on the debates heating up in Houston last week, the California Supreme C...

Read More >

Landmark Contractor Licensing Case Limits Disgorgement Remedy in California

Contractors performing work in California are required to be licensed by the California State Licens...

Read More >

The Improper Use of Governmental “Pre-Approved” Plans

There continues to be new, complicated problems arising from the improper completion and use of off-...

Read More >

COVID-19: What are the “Safer at Home” Orders?

California and the City of Los Angeles issued “safer at home” orders which have significantly impa...

Read More >